These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34454554)

  • 1. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p.
    Zhao Y; Yuan D; Zhu D; Xu T; Huang A; Jiang L; Liu C; Qian H; Bu X
    J Ovarian Res; 2021 Aug; 14(1):109. PubMed ID: 34454554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
    Miao S; Wang J; Xuan L; Liu X
    Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
    Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
    J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
    Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
    J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1.
    Liu X; Liu C; Zhang A; Wang Q; Ge J; Li Q; Xiao J
    World J Surg Oncol; 2021 Jul; 19(1):199. PubMed ID: 34218800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THUMPD3-AS1 inhibits ovarian cancer cell apoptosis through the miR-320d/ARF1 axis.
    Mu Q; Wang X; Huang K; Xia B; Bi S; Kong Y
    FASEB J; 2024 Jul; 38(13):e23772. PubMed ID: 38963337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
    Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis.
    Liu B; Yan L; Chi Y; Sun Y; Yang X
    J Ovarian Res; 2021 Apr; 14(1):60. PubMed ID: 33926489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
    Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
    Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
    [No Abstract]   [Full Text] [Related]  

  • 14. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
    Suo ST; Gong P; Peng XJ; Niu D; Guo YT
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of lncRNA ADPGK-AS1 on the proliferation and apoptosis of retinoblastoma cells by targeting miR-200b-5p].
    Xing F; Li YM; Gao MM
    Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):230-237. PubMed ID: 36944544
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.
    Liu HZ; Liu GY; Pang WW; Zhang H; Zeng ZJ; Wang HJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1682-1687. PubMed ID: 32141534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.